Tumor-cell-targeted cytokine gene therapy
- 31 July 1991
- journal article
- other
- Published by Elsevier in Immunology Today
- Vol. 12 (7) , 249-250
- https://doi.org/10.1016/0167-5699(91)90044-t
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Granulocyte colony-stimulating factor gene transfer suppresses tumorigenicity of a murine adenocarcinoma in vivo.The Journal of Experimental Medicine, 1991
- Decreased tumorigenicity of a transplantable rat sarcoma following transfer and expression of an IL‐2 cDNAInternational Journal of Cancer, 1991
- Interleukin 2 gene transfer into tumor cells abrogates tumorigenicity and induces protective immunity.The Journal of Experimental Medicine, 1990
- Retroviral interleukin 4 gene transfer into an interleukin 4‐dependent cell line results in autocrine growth but not in tumorigenicityEuropean Journal of Immunology, 1990
- Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor responseCell, 1990
- Tumor cell targeted cytokine (TNF-α) gene therapy for cancerImmunology Today, 1990
- Cells secreting tumour necrosis factor show enhanced metastasis in nude miceEuropean Journal of Cancer and Clinical Oncology, 1990
- Mechanisms of tumor-induced neutrophilia: constitutive production of colony-stimulating factors and their synergistic actionsBlood, 1989
- Murine interleukin-4 displays potent anti-tumor activity in vivoCell, 1989
- Tumors secreting human TNF/cachectin induce cachexia in miceCell, 1987